Recently funded

52North: funding, news and investors

About

A finger-prick blood test that flags chemotherapy patients at risk of neutropenic sepsis.

Sector · HealthTech
Based · Cambridge
Stage · Seed
Raised, tracked · £3.2m
Website · 52north.health

In the news

29 Sept 2026 · Funding round
52North raises £3.2m, led by Macmillan Ventures
✓ Follows the round

Also in HealthTech

Inovus Medical · Surgical training simulators using hydrogel anatomy models and software that tracks trainee performance.

DYAD · AI that turns clinical paperwork into structured NHS patient record data.

IMS Solutions · Biomarker and machine-learning diagnostic tests, including a urine test separating benign from malignant adrenal tumours.

Is this your company?

Claim the profile to add your raise, traction and the investors you're after. Free.

Claim this profile

Every item above was checked against the source linked beside it. Location is shown only where the source places the company in the UK. Not investment advice; InvestorUniverse does not verify every claim. Report this profile

If you are raising too

Get featured free, or see your top 3 matched investors free.